什么时候使用fluconazole

Same author

Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018.

Journal of clinical microbiology·2020

Same author

Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.

Journal of clinical microbiology·2019

Same author

Analysis of intra-hospital transfers and hospital-onset Clostridium difficile infection.

The Journal of hospital infection·2018

Same author

<i>In Vitro</i> Activities of the Benzoquinolizine Fluoroquinolone Levonadifloxacin (WCK 771) and Other Antimicrobial Agents against Mycoplasmas and Ureaplasmas in Humans, Including Isolates with Defined Resistance Mechanisms.

Antimicrobial agents and chemotherapy·2018

Same author

Colistin combination therapy improves microbiologic cure in critically ill patients with multi-drug resistant gram-negative pneumonia.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016

Same author

Patient-level analysis of incident vancomycin-resistant enterococci colonization and antibiotic days of therapy.

Epidemiology and infection·2016

Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026

Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

相关实验视频

什么时候使用fluconazole

相关概念视频

Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018.

Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.

Analysis of intra-hospital transfers and hospital-onset Clostridium difficile infection.

<i>In Vitro</i> Activities of the Benzoquinolizine Fluoroquinolone Levonadifloxacin (WCK 771) and Other Antimicrobial Agents against Mycoplasmas and Ureaplasmas in Humans, Including Isolates with Defined Resistance Mechanisms.

Colistin combination therapy improves microbiologic cure in critically ill patients with multi-drug resistant gram-negative pneumonia.

Patient-level analysis of incident vancomycin-resistant enterococci colonization and antibiotic days of therapy.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

相关实验视频

什么时候使用fluconazole

相关概念视频

相关文章

Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018.

Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.

Analysis of intra-hospital transfers and hospital-onset Clostridium difficile infection.

<i>In Vitro</i> Activities of the Benzoquinolizine Fluoroquinolone Levonadifloxacin (WCK 771) and Other Antimicrobial Agents against Mycoplasmas and Ureaplasmas in Humans, Including Isolates with Defined Resistance Mechanisms.

Colistin combination therapy improves microbiologic cure in critically ill patients with multi-drug resistant gram-negative pneumonia.

Patient-level analysis of incident vancomycin-resistant enterococci colonization and antibiotic days of therapy.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.